Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Zoetis Inc Cl A (ZTS)

Zoetis Inc Cl A (ZTS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 56,100,220
  • Shares Outstanding, K 440,693
  • Annual Sales, $ 9,256 M
  • Annual Income, $ 2,486 M
  • EBIT $ 3,462 M
  • EBITDA $ 3,959 M
  • 60-Month Beta 0.96
  • Price/Sales 6.09
  • Price/Cash Flow 18.02
  • Price/Book 10.46

Options Overview Details

View History
  • Implied Volatility 42.81% (+0.07%)
  • Historical Volatility 21.39%
  • IV Percentile 96%
  • IV Rank 84.95%
  • IV High 46.55% on 04/07/25
  • IV Low 21.70% on 02/20/25
  • Expected Move (DTE 9) 9.10 (7.10%)
  • Put/Call Vol Ratio 0.95
  • Today's Volume 3,856
  • Volume Avg (30-Day) 2,100
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 67,894
  • Open Int (30-Day) 64,296
  • Expected Range 119.04 to 137.23

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.40
  • Number of Estimates 11
  • High Estimate 1.41
  • Low Estimate 1.38
  • Prior Year 1.40
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
120.06 +6.72%
on 01/30/26
129.95 -1.40%
on 02/06/26
+0.96 (+0.75%)
since 01/09/26
3-Month
115.25 +11.18%
on 11/19/25
131.13 -2.29%
on 01/06/26
+8.34 (+6.96%)
since 11/10/25
52-Week
115.25 +11.18%
on 11/19/25
177.00 -27.61%
on 03/10/25
-43.78 (-25.47%)
since 02/10/25

Most Recent Stories

More News
Zoetis (ZTS) Reports Q4: Everything You Need To Know Ahead Of Earnings

Zoetis (ZTS) Reports Q4: Everything You Need To Know Ahead Of Earnings

ZTS : 128.13 (+0.65%)
Zoetis Declares Second Quarter 2026 Dividend

The Board of Directors of Zoetis Inc . (NYSE:ZTS) has declared a dividend of $0.53 per share for the second quarter of 2026. The dividend will be paid on Tuesday, June 2, 2026, to all holders...

ZTS : 128.13 (+0.65%)
Do Wall Street Analysts Like Zoetis Stock?

Zoetis stock has underperformed the broader market over the past year, while analysts remain cautiously bullish about its prospects.

XLV : 155.33 (-0.63%)
$SPX : 6,941.81 (-0.33%)
ZTS : 128.13 (+0.65%)
1 Cash-Producing Stock on Our Watchlist and 2 We Ignore

1 Cash-Producing Stock on Our Watchlist and 2 We Ignore

EYE : 27.77 (-3.24%)
MAT : 21.06 (-2.23%)
ZTS : 128.13 (+0.65%)
Q3 Earnings Roundup: Zoetis (NYSE:ZTS) And The Rest Of The Branded Pharmaceuticals Segment

Q3 Earnings Roundup: Zoetis (NYSE:ZTS) And The Rest Of The Branded Pharmaceuticals Segment

ZTS : 128.13 (+0.65%)
2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 Facing Challenges

2 of Wall Street’s Favorite Stocks with Solid Fundamentals and 1 Facing Challenges

CWH : 12.88 (-3.66%)
ZTS : 128.13 (+0.65%)
CDNS : 299.00 (+2.75%)
What to Expect From Zoetis' Next Quarterly Earnings Report

Zoetis is expected to announce its fiscal fourth-quarter earnings next month, and analysts project earnings in line with the year-ago quarter.

XLV : 155.33 (-0.63%)
$SPX : 6,941.81 (-0.33%)
ZTS : 128.13 (+0.65%)
1 Profitable Stock with Solid Fundamentals and 2 We Brush Off

1 Profitable Stock with Solid Fundamentals and 2 We Brush Off

CACC : 507.36 (+0.75%)
ARW : 156.02 (-1.32%)
ZTS : 128.13 (+0.65%)
2 Safe-and-Steady Stocks with Competitive Advantages and 1 We Turn Down

2 Safe-and-Steady Stocks with Competitive Advantages and 1 We Turn Down

ZTS : 128.13 (+0.65%)
NMIH : 40.19 (+0.63%)
LOPE : 169.65 (+0.87%)
Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2025 Financial Results

Zoetis Inc . (NYSE:ZTS) will host a webcast and conference call at 8:30 a.m. (ET) on Thursday, February 12, 2026. Chief Executive Officer Kristin Peck and Executive Vice President...

ZTS : 128.13 (+0.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified...

See More

Key Turning Points

3rd Resistance Point 131.18
2nd Resistance Point 130.39
1st Resistance Point 129.26
Last Price 128.13
1st Support Level 127.34
2nd Support Level 126.55
3rd Support Level 125.42

See More

52-Week High 177.00
Fibonacci 61.8% 153.41
Fibonacci 50% 146.13
Fibonacci 38.2% 138.84
Last Price 128.13
52-Week Low 115.25

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar